Study of Staph bacteria in NICU newborns
Part of Infections clinical trials.
This study looks at the germ Staphylococcus aureus in newborns in the neonatal intensive care unit (NICU). It aims to track how the germ spreads and understand its genes, which could help keep other babies safe.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Your baby is a newborn in the NICU
- Your baby is a carrier of a type of Staph called MSSA
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at germs that cause infections in newborns and which antibiotics work best against them. It aims to help doctors choose the right treatment for babies in the intensive care unit.
This study looks at how antibiotics affect MRSA (a type of staph infection) in the noses of hospitalized children. It may help doctors better understand MRSA to improve treatment.
This trial studies the bacteria living in the nose of patients with a staph bloodstream infection. It aims to better understand why some infections persist, which could lead to better treatments.
This study looks at the bacteria naturally found in breast milk. Researchers want to learn more about the germs in milk from mothers whose babies are in the neonatal intensive care unit.
This study tests whether giving one versus multiple doses of a special nasal treatment (called nasal microbiota therapy, or NMT) changes the types of helpful bacteria in your baby's nose. The goal is to see if the treatment keeps bad bacteria, like staph, from growing.
This study looks at how the antibiotic vancomycin moves through and acts in newborn babies. It may help doctors dose the medicine more safely and effectively for babies in intensive care.
Hear when a new the Aim of This Study is to Describe Genomic Epidemiology of MSSA in Neonatal ICU trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.